Glycopyrrolate Injection
Product Images NDC 51662-1487

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of glycopyrrolate, displaying its molecular formula C19H28BrNO3 and molecular weight 398.33. The structure includes a bicyclic ring with hydroxyl and ester functional groups, as well as a quaternary ammonium component.*

FDA Label Image

Clinical (Clinical Pharma)

A data table presenting pharmacokinetic parameters for glycopyrrolate at two dosage groups: 6 µg/kg intravenously (IV) and 8 µg/kg intramuscularly (IM). Parameters shown include half-life (t1/2), volume of distribution (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC), with some values and variability measures provided for each group.*

FDA Label Image

Vial Label (Vial Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a 1 mL single dose vial for intramuscular or intravenous use. The label indicates the presence of benzyl alcohol and is marked Rx only. It is distributed by West-Ward. The lot and expiration date fields are present but not filled.*

FDA Label Image

Rfid Label (51662 1487 1 Rfid Label)

A product label featuring a barcode and multiple identifier numbers including GTIN, batch or lot number, and expiration date information. The label references the manufacturer insert and states distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The text includes the code 'HF1234TESTING' and the label has a vertical barcode on the right side.*

FDA Label Image

Pouch Labeling (51662 1487 2 Pouch Labeling)

Label for GLYCOPYRROLATE Injection USP 0.2 mg/mL in a 1 mL vial containing benzyl alcohol. The label includes NDC 51662-1487-2, lot number 123456, and expiration date 01/01/2030. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. Instructions indicate use for intramuscular or intravenous administration and storage at controlled room temperature.*

FDA Label Image

Rfid Label (51662 1487 3 Rfid)

Label for GLYCOPYRROLATE injection, distributed by HF Acquisition Co LLC, DBA HealthFirst. The label includes NDC barcode and various identifier codes. It instructs to see manufacturer's insert and provides a distribution address in Mukilteo, WA.*

FDA Label Image

Box Labeling (51662 1487 3 Box Labeling)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, containing benzyl alcohol. The label indicates a 1 mL vial packaged in a box of 25. It includes the NDC number 51662-1487-3 and manufacturer information for HF Acquisition Co., LLC, Mukilteo, WA. The label specifies intramuscular and intravenous use and storage instructions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.